ICER To Release Final Assessment of Selected High-impact Drugs

ICER will be reviewing changes in the evidence base for each of these drugs and assess whether or not new clinical data exists that could suggest that the drugs could be significantly more beneficial for patients than what was previously understood. ICER published the final draft of its first UPI report in October 2019. Find out more here.